Torres OW

Language: Spanish
References: 8
Page: s128-s131
PDF size: 154.89 Kb.

Text Extraction

No abstract.

REFERENCES

1. Ji Y, Luo G, Fu Y. Incidence of anti-D alloimmunization inD-negative individuals receiving D-positive red blood celltransfusion: A systematic review and meta-analysis. Vox Sang. 2022; 117 (5): 633-640. doi: 10.1111/vox.13232.

2. Yazer MH, Spinella PC, Sperry J, Triulzi DJ, Leeper C. Timing ofRhD-positive red blood cell administration is associated withD-alloimmunization in injured patients. Transfusion. 2023; 63 Suppl

3. 3: S54-S59. doi: 10.1111/trf.17330.3. Yazer MH, Triulzi DJ, Sperry JL, Seheult JN. Rate of RhDalloimmunizationafter the transfusion of multiple RhD-positiveprimary red blood cell-containing products. Transfusion. 2021; 61Suppl 1: S150-S158. doi: 10.1111/trf.16495.

4. Gammon RR, Almozain N, Hermelin D, Klein N, Mangwana S, NairAR et al. RhD-Alloimmunization in adult and pediatric traumapatients. Transfus Med Rev. 2024; 38 (4): 150842. doi: 10.1016/j.tmrv.2024.150842.

5. Thibault L, de Grandmont MJ, Cayer MP, Dussault N, Jacques A,Ducas E et al. Rhesus D antigenic determinants on residual redblood cells in apheresis and buffy coat platelet concentrates.Transfus Med Hemother. 2020; 47 (2): 129-134. doi: 10.1159/000501106.

6. O’Brien KL, Haspel RL, Uhl L. Anti-D alloimmunization afterD-incompatible platelet transfusions: a 14-year single-institutionretrospective review. Transfusion. 2014; 54 (3): 650-654. doi: 10.1111/trf.12341.

7. de la Rubia J, García R, Arriaga F, Guinot M, López F, Marty ML.Anti-D immunization after transfusion of 4 units of fresh frozenplasma. Vox Sang. 1994; 66 (4): 297-298.

8. Jochumsen EA, Selleng K, Raval JS, Bub CB, Kutner JM, Sprogoe Uet al. Use of an anti-D-alloimmunization kinetics model to correctthe interval censored D-alloimmunization rate following red bloodcell transfusions. Transfusion. 2025; 65 Suppl 1(Suppl 1): S304-S312.doi: 10.1111/trf.18138.